Connect Sign In
Join ARUP at the 2025 AAN Annual Meeting to explore the latest in diagnostic laboratory testing for autoimmune neurology, including a presentation on a new biomarker test for Alzheimer's disease.
The rule and its compliance deadlines are no longer in effect, benefiting patient care, innovation, and the greater laboratory community, ARUP leaders said.
ARUP CEO Andy Theurer leads a group of university students through ARUP’s Automated Core Laboratory.
ARUP Laboratories and BioHive’s university student chapters collaborated to host a field trip at ARUP, where university students learned about laboratory science careers and toured the lab.
A comprehensive and detailed article by ARUP experts gives those responsible for anatomic pathology testing a resource for pertinent regulatory information to ensure compliance.
Recent measles outbreaks are concerning. To assist in detecting measles virus and determining immunity, ARUP currently provides testing for IgM and IgG antibodies.
Join ARUP at the 2025 ACMG annual meeting to explore the latest in laboratory genetics research, including how traditional and innovative test strategies can evaluate rare and undiagnosed cases.
Pramana, Inc., and ARUP are collaborating to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology.
ARUP Laboratories Expands AI-Augmented Parasitology Screening Tool, Improves Detection and Diagnosis
ARUP will expand its AI-augmented screening tool for the detection of human gastrointestinal parasites to become first and only lab to apply AI to the entire ova and parasite testing process.
Because an estimated one in 10 Americans lives with a rare disease, ARUP is committed to investing in the diagnostic research and innovation that will help bring them answers.
The award recognizes the work ARUP does to educate, advocate, and innovate while continuously pushing to improve patient care.
ARUP and other clinical labs anxiously await a decision by a federal court in Texas about whether the FDA overstepped its statutory authority.
Fallon Williams and her daughter have similar heart conditions, which do not have a known genetic cause. Williams hopes whole genome sequencing can provide answers and improve cardiac care for all.
